Bio Roundup: #JPM18, Axovant’s Fall, CRISPR Caveat, Impact M&A & More – Xconomy
Xconomy |
Bio Roundup: #JPM18, Axovant's Fall, CRISPR Caveat, Impact M&A & More
Xconomy Have you gotten your flu shot yet this year? This winter's flu season is shaping up to be a particularly nasty one and the Centers for Disease Control and Prevention this week upped its tally of states reporting widespread flu activity to 46. Flu … |
